Diagnostic Medical Systems SA
PAR:ALDMS
Cash Flow Statement
Cash Flow Statement
Diagnostic Medical Systems SA
| Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Net Income |
(10)
|
(5)
|
(9)
|
(9)
|
(0)
|
(5)
|
(10)
|
(3)
|
(2)
|
|
| Depreciation & Amortization |
3
|
4
|
4
|
3
|
3
|
4
|
4
|
0
|
1
|
|
| Change in Deffered Taxes |
0
|
0
|
0
|
4
|
0
|
0
|
0
|
2
|
2
|
|
| Other Non-Cash Items |
6
|
0
|
5
|
(0)
|
(9)
|
0
|
4
|
(0)
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Change in Working Capital |
(3)
|
(0)
|
(1)
|
2
|
2
|
(1)
|
3
|
5
|
3
|
|
| Cash from Operating Activities |
(4)
N/A
|
(1)
+69%
|
(1)
-34%
|
0
N/A
|
0
+6%
|
(2)
N/A
|
1
N/A
|
4
+175%
|
3
-31%
|
|
| Investing Cash Flow | ||||||||||
| Other Items |
1
|
(3)
|
(1)
|
(3)
|
(5)
|
(1)
|
(2)
|
(3)
|
(2)
|
|
| Cash from Investing Activities |
1
N/A
|
(3)
N/A
|
(1)
+62%
|
(3)
-200%
|
(5)
-65%
|
(1)
+71%
|
(2)
-46%
|
(3)
-35%
|
(2)
+20%
|
|
| Financing Cash Flow | ||||||||||
| Net Issuance of Common Stock |
0
|
0
|
1
|
6
|
5
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
2
|
6
|
3
|
(3)
|
(0)
|
3
|
(1)
|
1
|
2
|
|
| Other |
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(1)
|
(1)
|
|
| Cash from Financing Activities |
2
N/A
|
6
+204%
|
4
-30%
|
3
-30%
|
5
+47%
|
3
-23%
|
(1)
N/A
|
(0)
+86%
|
1
N/A
|
|
| Change in Cash | ||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Net Change in Cash |
(1)
N/A
|
2
N/A
|
2
-24%
|
0
-87%
|
(0)
N/A
|
0
N/A
|
(2)
N/A
|
1
N/A
|
1
+43%
|
|
| Free Cash Flow | ||||||||||
| Free Cash Flow |
(4)
N/A
|
(1)
+69%
|
(1)
-34%
|
0
N/A
|
0
+6%
|
(2)
N/A
|
1
N/A
|
4
+175%
|
3
-31%
|
|